Navigation Links
Unrelated Cord Blood Helps Infants With Metabolic Disorders
Date:12/10/2007

It's a viable option with lower risk of complications, study finds

MONDAY, Dec. 10 (HealthDay News) -- Umbilical cord transplants from unrelated donors can benefit infants born with life-threatening metabolic disorders such as Hurler disease and Krabbe leukodystrophy, according to a study led by Duke University Medical Center researchers.

These kinds of metabolic disorders -- which cause organ failure and early death -- occur in about one in 10,000 births. Without intervention, most children with these disorders die before they reach their first birthday.

Bone marrow transplantation has been the traditional way of treating these disorders but can only be done using a matched donor. Both bone marrow and umbilical cord blood transplant replace missing enzymes and allow affected organs to develop more normally.

This study included 159 children with inherited metabolic disorders who received unrelated donor cord blood transplants at Duke between 1995 and 2007.

"We saw that there were advantages to the unrelated cord blood transplant," lead investigator Dr. Vinod Prasad, a pediatric hematologist/oncologist at Duke, said in a prepared statement. "For instance, cord blood is more readily available than bone marrow, and there was a decreased risk of complications, including a lower incidence of serious and potentially fatal graft-versus-host disease, which occurs when donor cells perceive a recipient's tissues and organs as foreign."

The study results also suggest that patients who receive cord blood transplants while they're still relatively healthy have better outcomes than those who receive bone marrow transplants.

"Over 88 percent of this subset of patients were alive one year after their cord blood transplants, and close to 80 percent were alive five years afterwards. One reason for this could be the cord blood cells are immunologically more naive than the blood-forming stem cells derived form bone marrow and therefore they may be more adaptable and less reactive once they get into the patient's body," Prasad said.

The study was expected to be presented Monday at the American Society of Hematology annual meeting in Atlanta.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about Krabbe disease.



-- Robert Preidt



SOURCE: Duke University, news release, Dec. 10, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Mini transplant patients outcomes similar using related and unrelated donor cells
2. Specific antagonism lowers blood pressure
3. Restricting Blood Flow May Help Heart Bypass Patients
4. FDA Updates Prescription Guidelines for Blood Thinner
5. Doctors Often Miss High Blood Pressure in Kids
6. Back to School Means Return of School Blood Drives
7. Blood-flow detector software show promise in preventing brain damage
8. FDA Approves New Roche West Nile Virus Blood Screening Test
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. Laser blasts viruses in blood
11. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... ... of commercial real estate proudly announced that its service-based charitable program, Olshan Outreach, ... members portfolio-wide will continue Olshan Properties’ annual philanthropic tradition in 2016 with the ...
(Date:5/4/2016)... Columbia, MD (PRWEB) , ... May 04, 2016 ... ... Wound, Ostomy and Continence Nurses (WOCN) Society™ and Canadian Association for Enterostomal ... matchmaking, event promotion, time saving and planning tools to attendees and exhibitors for ...
(Date:5/4/2016)... ... 2016 , ... All-Star Insurance of Northeast TX has announced ... their local community. The agency pledges to select a new beneficiary every 60 ... bring awareness to important local causes with fundraising and other support, by forming ...
(Date:5/4/2016)... Island (PRWEB) , ... May 04, 2016 , ... ... in April 2016. SS&A teamed up with one of the top website design ... information portal contains informative legal articles related to the law firm's main practice ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... foundational nutrients that supports cellular and metabolic health. This synergistic combination of omega-3 ... free-form curcumin, along with 150 mg of reduced glutathione and 200 mg of ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 Valeritas Holdings, ... an alternative public offering (APO). This was accomplished via ... Valeritas, Inc. and a private placement of approximately 5 ... per share. Under the terms of the ... Valeritas Holdings, Inc. will trade on the OTC Markets ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Actinic Keratosis Market ... to their offering.       (Logo: ... Keratosis Market and Competitive Landscape Highlights 2016, ... products, Actinic Keratosis epidemiology, Actinic Keratosis market ...
(Date:5/3/2016)... , May 4, 2016 Research ... "Global Cancer Stem Cell Therapy Market Outlook 2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has improved significantly ... expected to be developed in coming years. Many cancer ... Cancer stem cell therapies are also expected to be ...
Breaking Medicine Technology: